Company Category: Books/Journals/Publishing

Wiley’s Advanced Portfolio

Advanced Oncology, part of Wiley’s Advanced Portfolio of high impact collaborative journals, accelerates breakthrough cancer research with clarity, speed, and purpose. We publish across basic, translational, and clinical oncology. The Advanced portfolio from Wiley is a family of globally respected, high-impact journals, including interdisciplinary journal Advanced Science, that disseminate the best science from well-established and emerging researchers to fulfill their mission and maximize the reach of their scientific discoveries. advanced.onlinelibrary.wiley.com

Read More

The Cancer Epitope Database and Analysis Resource (CEDAR)

The Cancer Epitope Database and Analysis Resource (CEDAR – cedar.iedb.org) is a freely available resource funded by NCI. It catalogs experimental data on antibody and T cell epitopes studied in humans in the context of cancer disease. CEDAR also hosts tools to assist in the prediction and analysis of cancer epitopes. CEDAR is a companion site to the Immune Epitope Database (IEDB – iedb.org), which is funded by NIAID, and houses epitope data on infectious disease, allergy, autoimmunity and transplantation.

Read More

Taylor & Francis

Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress. Under the Taylor & Francis, Routledge and F1000 imprints, we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies. BioTechniques is a joint journal and digital hub covering the latest in technological and methodological updates across the life sciences. Our digital hub delivers news, videos, infographics, eBooks and engaging podcasts for members to enjoy and provides the opportunity to join our global community of lab researchers, industry experts and budding scientists.

Read More

Springer Nature

Springer Nature is a leading global scientific, technical and medical portfolio, providing researchers with quality content through innovative products and services from trusted brands like Springer, Nature Portfolio, and BMC. Springer Nature has one of the strongest STM and HSS eBook collections and a comprehensive range of hybrid and open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display. | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit our booth to learn about publishing with us. | Springer Nature is a leading global research, educational and professional publisher, home to an array of trusted brands, including Springer, Nature Portfolio, Palgrave Macmillan, BioMed Central, and Scientific American. We provide quality content for the Genetics community through innovative products and services, extensive eBook collections, and hybrid/open access journals across the sciences and humanities. Meet with our editors to learn about the benefits of publishing with us. Find out more: www.springernature.com | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit springernature.com and @SpringerNature. | Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature advances discovery by publishing trusted research, supporting the development of new ideas and championing open science. We are committed to playing our part in accelerating solutions to address the world’s urgent challenges. The newest addition to the Springer Nature family of products is protocols.io, a secure platform for developing, optimizing, sharing, and running reproducible research methods. | Springer Nature Information and insights to drive research, development and excellence Fuel your innovation pipeline and improve commercial outcomes with Springer Nature’s comprehensive portfolio of content and solutions. With over 150 years of expertise in scientific publishing, we are a trusted partner to life sciences organizations, providing the insights, data and platforms needed to accelerate research, enhance decision-making, and drive business success. Our solutions empower biopharma and biotech professionals to stay ahead in a rapidly evolving industry: AdisInsight Make confident decisions in drug development In the fast-paced world of biopharma, every decision counts. AdisInsight provides trusted, expertly curated intelligence on drug development, clinical trials, deals and safety, empowering you to act with certainty. Stay Ahead: Updated daily with the latest drug and trial data. Trust Your Data: Expert-validated insights with full transparency on sources. Seamless Integration: Plug directly into your internal analytics for deeper insights. Strategic Advantage: Identify opportunities, track competitors and accelerate decision-making. Navigate drug development with confidence with AdisInsight. adisinsight.springer.com Biopharma Dealmakers Make biopharma connections today Biopharma Dealmakers is the premier platform connecting life sciences innovators, investors and pharma leaders. Get exclusive deal insights, funding trends and opportunities to showcase your company. Trusted Industry Insights: Editorial coverage on M&A, licensing, and funding. Global Reach: Distributed with Nature Biotechnology and Nature Reviews Drug Discovery. Partnering Opportunities: Feature your company’s assets, innovations and investment needs. Branded Content: Tailored campaigns to position your company in front of the right audience. Connect, partner and accelerate your next deal with Biopharma Dealmakers. nature.com/biopharmdeal protocols.io Accelerate innovation with reproducible research protocols.io is a secure, interactive platform for developing and sharing research methods, ensuring standardization, collaboration, and compliance. Reproducibility First: Step-by-step protocols with version tracking. Seamless Collaboration: Share, comment, and refine methods in real time. Compliance-Ready: Supports HIPAA and 21 CFR Part 11 compliance. Institutional Knowledge: Preserve protocols and expertise within your organization. Streamline research and ensure reproducibility with protocols.io. protocols.io Nature Portfolio Engage the STEM community with impact Reach a global community of scientists, healthcare professionals and decision-makers with Nature Portfolio’s advertising and content solutions. Unmatched Reach: 55M monthly users, 6.5M newsletter subscribers, 100K podcast listeners. Precision Targeting: Data-driven campaigns for maximum engagement. Multi-Channel Advertising: Digital, print, email and podcast options. Branded Content: Award-winning storytelling aligned with Nature’s trusted voice. Align your brand with scientific excellence—partner with Nature Portfolio. partnerships.nature.com Text and Data Mining (TDM) With the ever-expanding volume of valuable information becoming available daily, any fragment of it could hold the key to the next breakthrough. By analysing this information, and uncovering patterns and trends, you can get the insights you need to fast-track innovation. By choosing Springer Nature’s API as your data source, you’ll have access to our extensive collection of high-quality groundbreaking research, across all subject areas. All of our data is from a trusted, peer-reviewed content source, giving you information you can trust and ultimately leading to higher quality output. You can apply our data to meet a limitless range of business goals, from understanding trending topics to finding potential collaborators to building new products. Data Solutions (TDM) | Springer Nature is a leading global scientific, technical and medical publisher, providing researchers with innovative information, products and services. | Springer is a leading global research publisher, providing researchers with quality Radiology content through innovative information, products and services. As part of Springer Nature, Springer sits alongside other trusted brands like Nature Portfolio and BMC to provide a comprehensive range of books, eBook collections, and hybrid/open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display.

Read More

Society for Immunotherapy of Cancer

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC is a 501(c)(3) not-for-profit organization.

Read More

Science/AAAS

Since 1848, AAAS and its members have worked together to advance science and serve society. As part of these efforts, AAAS publishes Science, a multidisciplinary peer-reviewed journal, Science Advances, an open-access online journal, Science Immunology, Science Robotics, Science Signaling, and Science Translational Medicine. AAAS also offers programs focused on science policy, international cooperation, science education, diversity, and career development for scientists.

Read More

OncLive

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Read More

OAE Publishing Inc.

OAE Publishing Inc. (OAE) is a multidisciplinary open access academic publisher founded on March 17, 2015. Headquartered in Los Angeles, USA, OAE is wholly owned by Mesa Investment Management Inc. As a platform-driven, internationally oriented publisher, OAE has built a fully integrated system that supports the entire scholarly publishing lifecycle. The company operates a suite of proprietary, independently developed infrastructures, including an intelligent manuscript submission and peer-review system (MESAS), a digital publishing platform, and a preprint server (ScieRxiv). These platforms are supported by a dedicated Digital Production Team and specialized service units, including the Operations and Management Team, the Publishing Department, the Manuscript Processing Center, the Language Editing Team, and the Marketing and Social Media Team. Through this comprehensive framework, OAE provides structured, standardized, and professional publishing services for researchers, academic institutions, and scholarly organizations worldwide. By prioritizing quality, efficiency, and transparency, OAE supports the dissemination of high-quality research and contributes to the sustainable advancement of open science.

Read More

NORD Rare Cancer Coalition

The Rare Cancer Coalition, formalized in 2017 as a program under the NORD Membership umbrella, unites advocacy organizations working in rare cancers to collaborate on issues facing their communities. Our goal is to eliminate the challenges faced by people affected by rare cancers through: Global awareness through campaigns such as #RareCancerDay, and representation at major events Publications and medical education Patient and caregiver education Collaborative networking and peer-to-peer mentoring Capacity building for Rare Cancer Patient Advocacy Groups

Read More

MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. Based in Basel, Switzerland, MDPI has the mission to foster open scientific exchange in all forms, across all disciplines.

Read More